Author

Maja Lampelj

Observed name: M. Lampelj

Institution: University Clinical Centre Maribor

Observed institutions: University of Maribor, University Clinical Centre Maribor

OpenAlex ID: A5040211372

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors

2015 · Maja Lampelj, Darja Arko, et al. · Radiology and Oncology · 38

The role of the urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in breast cancer

2011 · Iztok Takač, Tanja Čufer, et al. · Slovenian Medical Journal · 2

Efficacy of intraoperative application of levobupivacaine on postoperative analgesia after cesarean section

2016 · Veronika Anzeljc, Faris Mujezinović, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology

Correlation of traditional prognostic factors in breast cancer with HER2 status, urokinase plasminogen activator and plasminogen activator inhibitor-1

2016 · Iztok Takač, Maja Lampelj, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology

Efficacy of mifepristone and misoprostol in termination of pregnancy in second and third trimester versus intraamniotic application of prostaglandins

2016 · Veronika Anzeljc, Faris Mujezinović, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology

Expression of invasive markers (uPA/PAI-1) in four different HER ER, PR subgroups of early breast cancer

2008 · M. Ravnik, I. Takac, et al. · European Journal of Cancer Supplements

Works count: 6

Citation count: 40

H-index: 2

I10-index: 1